Varvara Kommata
@KommataVarvara
Followers
162
Following
493
Statuses
1K
Cardiologist, Electrophysiologist, Uppsala University Hospital, Sweden
Uppsala, Sverige
Joined August 2020
RT @hcmsociety: How can late gadolinium enhancement on cardiac MRI help predict sudden cardiac death risk in hypertrophic cardiomyopathy? T…
0
3
0
RT @EHRAPresident: If you haven't done so, take a look at the #EHRA_ESC position paper on the use of leadless and extravascular CIEDs @Euro…
0
5
0
RT @EHRAPresident: #EHRAtopicweek A novel approach to non-transvenous ICD therapy is extravascular ICD ⚡️ It utilizes a substernal lead, d…
0
40
0
RT @EHRAPresident: 🚨 Exciting News for EHRA 2025! 🚨 ⏳ The Late-Breaking Clinical Trial submission deadline has been extended to Thursday,…
0
8
0
RT @ProtonotariosA: Excited to share the state of the art review on “Naxos Disease and Related Cardio-Cutaneous Syndromes”. Well done to @A…
0
8
0
RT @RodrigueGarcia4: Important paper on 🇩🇰 sudden cardiac death epidemiology published in @CircAHA 🚀 @CarlJohannH @JacobTfelt @bowinkel75…
0
2
0
RT @EHRAPresident: VANISH2 found a significant reduction of the 1° endpoint, being the treated episodes below ICD rate the main driver for…
0
2
0
RT @EHRAPresident: #EHRAtopicweek brings you the VANISH 2 trial! 400 post-MI patients with VT (median LVEF 34%) randomized to AADs or RF ab…
0
12
0
RT @RigsHeart: Just out @CircAHA 📢 SCD rates in young have dropped by 49% over 20 years - driven by better OHCA survival, diagnostics, an…
0
2
0
RT @EHRAPresident: - 123 patients randomised in 2 centers in UK - 62 Ablations⚡️, 61 Sham procedures - Significantly ⬇️ AF Burden after per…
0
1
0
RT @EHRAPresident: #EHRAtopicweek on Best Evidence in EP What can provide better evidence for #AFib ablation than the SHAM-PVI trial, pres…
0
8
0
RT @escardio: Atrial fibrillation: what patients need to know This new document provides a summary of the key aspects of the guidelin…
0
11
0
RT @EHRAPresident: #EHRAweekendreads Lifestyle management for AF – focus on obesity management See ESC consensus document on obesity and c…
0
5
0
RT @EHRAPresident: #EHRA_ESC is conducting a survey on Lifestyle and risk factor modification in #AFib 📃 Share 🫵 thoughts, opinion and ex…
0
8
0
RT @EHRAPresident: #EHRA_ESC Call for joint sessions extended deadline until 30 October! #EHRA_ESC collaborates with EP National Cardiac S…
0
6
0
RT @EHRAPresident: #EHRAtopicweek on Gender Differences in EP ♂️♀️ Listen to the latest #EHRA_ESC Cardio Talk episode! 🎙️ Join experts @ne…
0
9
0
RT @Dominik_Linz: #EPeeps #ACNAPTopicOfTheMonth Between 2010 and 2019, the global 🌎 prevalence of #AFib has risen markedly 📈 from 33.5 mi…
0
11
0
RT @JACCJournals: #GCOS2024 #JACCCardioOnc SimPub: #SGLT2i administration was associated with a significantly decreased risk of developing…
0
55
0
RT @ZHeart11768530: 🔴 Contemporary approach to cardiogenic shock care: a state-of-the-art #2024Review #openaccess
0
73
0
RT @ehj_ed: Large nationwide registry of post-MI pts with LVEF ≤ 35% who were implanted with an ICD after being prescribed a wearable cardi…
0
19
0